Camilla Evangelisti
University of Bologna(IT)
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Acute Lymphoblastic Leukemia research, Chronic Myeloid Leukemia Treatments, Protein Kinase Regulation and GTPase Signaling, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance(2006)2,275 cited
- → Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging(2011)695 cited
- → Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health(2011)575 cited
- → Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia(2006)335 cited
- → Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance(2012)315 cited
- → Mutations and Deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascades Which Alter Therapy Response.(2012)302 cited
- → Current treatment strategies for inhibiting mTOR in cancer(2014)262 cited
- → Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy(2011)261 cited
- → The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients(2010)250 cited
- → Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway(2011)203 cited